Ken Fisher’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.95B | Buy |
104,964,427
+53,012,321
| +102% | +$1.41B | 1% | 27 |
|
|
2025
Q4 | $1.29B | Buy |
51,952,106
+2,664,052
| +5% | +$67.2M | 0.44% | 66 |
|
|
2025
Q3 | $1.26B | Buy |
49,288,054
+897,786
| +2% | +$22.2M | 0.45% | 66 |
|
|
2025
Q2 | $1.17B | Buy |
48,390,268
+950,239
| +2% | +$22.2M | 0.47% | 65 |
|
|
2025
Q1 | $1.2B | Buy |
47,440,029
+36,291,913
| +326% | +$950M | 0.52% | 61 |
|
|
2024
Q4 | $296M | Buy |
11,148,116
+4,938,209
| +80% | +$134M | 0.12% | 107 |
|
|
2024
Q3 | $180M | Buy |
6,209,907
+4,309,076
| +227% | +$126M | 0.07% | 134 |
|
|
2024
Q2 | $53.2M | Sell |
1,900,831
-2,394
| -0.1% | -$65.9K | 0.02% | 217 |
|
|
2024
Q1 | $52.8M | Buy |
1,903,225
+15,888
| +0.8% | +$441K | 0.02% | 220 |
|
|
2023
Q4 | $54.3M | Sell |
1,887,337
-46,423
| -2% | -$1.4M | 0.03% | 211 |
|
|
2023
Q3 | $64.1M | Buy |
1,933,760
+9,537
| +0.5% | +$337K | 0.04% | 217 |
|
|
2023
Q2 | $70.6M | Buy |
1,924,223
+463
| +0% | +$18K | 0.04% | 223 |
|
|
2023
Q1 | $78.5M | Sell |
1,923,760
-31,983
| -2% | -$1.38M | 0.05% | 212 |
|
|
2022
Q4 | $100M | Sell |
1,955,743
-99,745
| -5% | -$4.78M | 0.07% | 177 |
|
|
2022
Q3 | $89.9M | Sell |
2,055,488
-404,984
| -16% | -$19.7M | 0.07% | 183 |
|
|
2022
Q2 | $129M | Sell |
2,460,472
-12,419
| -0.5% | -$633K | 0.09% | 141 |
|
|
2022
Q1 | $128M | Sell |
2,472,891
-34,667
| -1% | -$1.8M | 0.08% | 147 |
|
|
2021
Q4 | $148M | Buy |
2,507,558
+63,262
| +3% | +$3.13M | 0.08% | 149 |
|
|
2021
Q3 | $105M | Sell |
2,444,296
-2,276
| -0.1% | -$101K | 0.07% | 164 |
|
|
2021
Q2 | $95.8M | Sell |
2,446,572
-38,794
| -2% | -$1.51M | 0.06% | 178 |
|
|
2021
Q1 | $90M | Sell |
2,485,366
-58,521
| -2% | -$2.08M | 0.06% | 175 |
|
|
2020
Q4 | $93.6M | Buy |
2,543,887
+45,863
| +2% | +$1.68M | 0.07% | 167 |
|
|
2020
Q3 | $87M | Sell |
2,498,024
-86,780
| -3% | -$3.04M | 0.08% | 157 |
|
|
2020
Q2 | $80.2M | Sell |
2,584,804
-3,157,553
| -55% | -$107M | 0.08% | 154 |
|
|
2020
Q1 | $178M | Sell |
5,742,357
-42,083,075
| -88% | -$1.43B | 0.22% | 94 |
|
|
2019
Q4 | $1.78B | Buy |
47,825,432
+88,299
| +0.2% | +$3.15M | 1.8% | 11 |
|
|
2019
Q3 | $1.63B | Buy |
47,737,133
+1,220,686
| +3% | +$44.4M | 1.79% | 9 |
|
|
2019
Q2 | $1.91B | Buy |
46,516,447
+1,643,613
| +4% | +$65.3M | 2.11% | 9 |
|
|
2019
Q1 | $1.81B | Buy |
44,872,834
+783,267
| +2% | +$31.4M | 2.12% | 8 |
|
|
2018
Q4 | $1.83B | Buy |
44,089,567
+1,426,039
| +3% | +$59.2M | 2.49% | 6 |
|
|
2018
Q3 | $1.78B | Buy |
42,663,528
+1,088,375
| +3% | +$41.9M | 2.17% | 8 |
|
|
2018
Q2 | $1.43B | Buy |
41,575,153
+1,761,561
| +4% | +$60.2M | 1.86% | 11 |
|
|
2018
Q1 | $1.34B | Buy |
39,813,592
+1,477,136
| +4% | +$50.8M | 1.78% | 11 |
|
|
2017
Q4 | $1.32B | Buy |
38,336,456
+1,319,134
| +4% | +$45M | 1.72% | 13 |
|
|
2017
Q3 | $1.25B | Buy |
37,017,322
+1,144,050
| +3% | +$36.8M | 1.76% | 11 |
|
|
2017
Q2 | $1.14B | Buy |
35,873,272
+1,344,727
| +4% | +$42.4M | 1.72% | 11 |
|
|
2017
Q1 | $1.12B | Buy |
34,528,545
+584,735
| +2% | +$18.4M | 1.79% | 11 |
|
|
2016
Q4 | $1.05B | Buy |
33,943,810
+388,278
| +1% | +$11.9M | 1.82% | 10 |
|
|
2016
Q3 | $1.08B | Buy |
33,555,532
+117,877
| +0.4% | +$3.94M | 1.91% | 9 |
|
|
2016
Q2 | $1.15B | Sell |
33,437,655
-22,785
| -0.1% | -$727K | 2.13% | 5 |
|
|
2016
Q1 | $1.03B | Sell |
33,460,440
-620,036
| -2% | -$17.7M | 1.96% | 8 |
|
|
2015
Q4 | $1.04B | Buy |
34,080,476
+429,546
| +1% | +$13.5M | 2.01% | 8 |
|
|
2015
Q3 | $1B | Buy |
33,650,930
+116,077
| +0.3% | +$3.72M | 2.09% | 6 |
|
|
2015
Q2 | $1.07B | Buy |
33,534,853
+641,335
| +2% | +$20.9M | 2.07% | 5 |
|
|
2015
Q1 | $1.09B | Buy |
32,893,518
+12,497
| +0% | +$397K | 2.17% | 4 |
|
|
2014
Q4 | $972M | Sell |
32,881,021
-533,409
| -2% | -$15.3M | 2.01% | 7 |
|
|
2014
Q3 | $937M | Buy |
33,414,430
+231,887
| +0.7% | +$6.51M | 2% | 8 |
|
|
2014
Q2 | $934M | Buy |
33,182,543
+1,306,909
| +4% | +$37.3M | 1.96% | 9 |
|
|
2014
Q1 | $971M | Sell |
31,875,634
-211,100
| -0.7% | -$6.29M | 2.19% | 7 |
|
|
2013
Q4 | $932M | Sell |
32,086,734
-286,001
| -0.9% | -$8.32M | 2.11% | 7 |
|
|
2013
Q3 | $882M | Sell |
32,372,735
-27,180
| -0.1% | -$740K | 2.17% | 4 |
|
|
2013
Q2 | $861M | Buy |
+32,399,915
| New | +$895M | 2.24% | 4 |
|
Other funds holding PFE
VCM
VPM
Ken Fisher's PFE Position: Q1 2026 in Review
Ken Fisher increased its Pfizer (PFE) stake by 102% in Q1 2026, buying an estimated $1.41B and bringing the position to 104,964,427 shares worth $2.95B. The position accounts for 1% of the portfolio, ranked #27.
Ken Fisher first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Ken Fisher held 104,964,427 shares of Pfizer worth $2.95B as of Q1 2026.
- Ken Fisher bought 53,012,321 Pfizer shares in Q1 2026, an estimated $1.41B.
- Pfizer made up 1% of Ken Fisher's portfolio in Q1 2026, its #27 holding.
- Ken Fisher first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Fisher Asset Management's 13F filing for Q1 2026, filed 5 May 2026.